Tenax Therapeutics (TENX) Interest Coverage Ratio (QoQ) (2010 - 2024)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Tenax Therapeutics | 542.72 Mn | 542.72 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1,205.54% |
| Sep 30, 2024 | -61.77% |
| Jun 30, 2024 | 16.52% |
| Mar 31, 2024 | 91.86% |
| Dec 31, 2023 | -1,612.92% |
| Sep 30, 2023 | 192.89% |
| Jun 30, 2023 | 164.67% |
| Sep 30, 2022 | 306.67% |
| Jun 30, 2022 | 83.51% |
| Jun 30, 2021 | 115.09% |
| Mar 31, 2021 | -3,714.14% |
| Dec 31, 2020 | 129.39% |
| Sep 30, 2020 | 30.93% |
| Dec 31, 2015 | -27.28% |
| Sep 30, 2015 | -56.46% |
| Apr 30, 2013 | -2.67% |
| Jan 31, 2013 | -146.04% |
| Oct 31, 2012 | 9.52% |
| Jul 31, 2012 | 64.42% |
| Apr 30, 2012 | -596.98% |
| Jan 31, 2012 | 85.11% |
| Oct 31, 2011 | 57.71% |
| Jul 31, 2011 | 75.11% |
| Apr 30, 2011 | 64.99% |
| Jan 31, 2011 | -116.73% |
| Oct 31, 2010 | -84.76% |